Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 4/20 | 0.58 |
| ▸ | CA1 | P00915 | 2/20 | 0.58 |
| ▸ | DGKA | P23743 | 1/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.51 |
| ▸ | TSHR | P16473 | 1/20 | 0.51 |
| ▸ | ATM | Q13315 | 1/20 | 0.51 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.51 |
| ▸ | LMNA | P02545 | 4/20 | 0.49 |
| ▸ | MAPT | P10636 | 2/20 | 0.49 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | PAM | P19021 | 2/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6871650 | 1.00 | CA2 (0.58) | CA2CA1DGKACYP3A4TSHR | |
| SCHEMBL8609372 | 1.00 | CA2 (0.58) | CA2CA1DGKACYP3A4TSHR | |
| SCHEMBL27638910 | 1.00 | CA2 (0.58) | CA2CA1DGKACYP3A4TSHR | |
| SCHEMBL1833536 | 1.00 | CA2 (0.58) | CA2CA1DGKACYP3A4TSHR | |
| SCHEMBL3442017 | 0.98 | CA2 (0.56) | CA2CA1DGKACYP3A4TSHR | |
| SCHEMBL11139751 | 0.98 | CA2 (0.56) | CA2CA1DGKACYP3A4TSHR | |
| SCHEMBL9222986 | 0.98 | CA2 (0.56) | CA2CA1DGKACYP3A4TSHR | |
| SCHEMBL240951 | 0.98 | CA2 (0.59) | CA2CA1DGKACYP3A4TSHR | |
| SCHEMBL28481500 | 0.97 | CA2 (0.53) | CA2CA1DGKACYP3A4TSHR | |
| SCHEMBL17476745 | 0.96 | CA2 (0.61) | CA2CA1DGKACYP3A4TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 61 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12514879-B2 | Use of acellular adipose tissue extract in promoting hair growth and retention | SHANGHAI CELLEAF BIOTECHNOLOGY CO., LTD. (CN) | 2026-01-06 | — | — | US | disclosed |
| EP-4046625-B1 | USE OF ACELLULAR ADIPOSE TISSUE EXTRACT IN PROMOTING HAIR GROWTH AND RETENTION | SHANGHAI CELLEAF BIOTECHNOLOGY CO LTD (CN) | 2025-08-20 | — | — | EP | disclosed |
| EP-4527371-A1 | PREPARATION METHOD FOR AND USE OF INCLUSION OF RETINOL AND DERIVATIVE THEREOF | Shanghai Oli Enterprises Co., Ltd. (CN) | 2025-03-26 | — | — | EP | disclosed |
| CN-118252915-A | Medicine for treating pigmentation | 上海萨丽斐生物科技有限公司 | 2024-06-28 | — | — | CN | disclosed |
| CN-118255914-A | Copolymer having carbosiloxane dendrimer structure, and composition, cosmetic raw material, film-forming agent and cosmetic containing the copolymer | 陶氏东丽株式会社 | 2024-06-28 | — | — | CN | disclosed |
| CN-118221558-A | Vitamin A acid derivative and preparation method and application thereof | 上海瑞替诺医药科技有限公司 | 2024-06-21 | — | — | CN | disclosed |
| CN-118203650-A | Medicine for treating pigmentation | 上海萨丽斐生物科技有限公司 | 2024-06-18 | — | — | CN | disclosed |
| CN-118001376-A | Use of annexin A5 for promoting hair growth, nourishing hair, caring hair, preventing alopecia, and treating alopecia, and related products and pharmaceutical compositions | 上海萨美细胞技术有限公司 | 2024-05-10 | — | — | CN | disclosed |
| CN-114939079-B | Preparation method and application of retinol and its derivative inclusion | 上海奥利实业有限公司 | 2024-04-23 | — | — | CN | disclosed |
| CN-117815098-A | Anti-aging polypeptide component for activating PPAR pathway and application thereof | 上海乐循理生物科技有限公司 | 2024-04-05 | — | — | CN | disclosed |
| CN-112386528-A | Fat extract without additive components, and its preparation method and application | 上海萨美细胞技术有限公司 | 2021-02-23 | — | — | CN | disclosed |
| WO-2021027971-A1 | FAT EXTRACT WITHOUT ADDED INGREDIENTS, PREPARATION METHOD THEREFOR AND USE THEREOF | 上海萨美细胞技术有限公司 | 2021-02-18 | — | — | WO | disclosed |
| CN-112203637-A | Aerosol cosmetic product | 花王株式会社 | 2021-01-08 | — | — | CN | disclosed |
| CN-111281812-A | Application of cajanin | 深圳市前海博斐生物科技有限公司 | 2020-06-16 | — | — | CN | disclosed |
| WO-2020052571-A1 | USE OF COMBRETUM MICRANTHUM EXTRACT IN COSMETICS | 爱卡德玛（亚洲）有限公司 | 2020-03-19 | — | — | WO | disclosed |
| CN-110882189-A | Use of extract of Graptopetalum paraguayense in cosmetics | 肌译生物科技有限公司 | 2020-03-17 | — | — | CN | disclosed |
| US-8263117-B2 | C70-containing liposome, method for producing the same, and use of the same | National University Corporation NARA Institute of Science and Technology (JP) | 2012-09-11 | — | — | US | disclosed |
| EP-2123288-B1 | C70 FULLERENE-CONTAINING LIPOSOME, METHOD FOR PRODUCING THE SAME, AND USE OF THE SAME | NAT UNIV CORP NARA INST (JP) | 2011-05-04 | — | — | EP | disclosed |
| US-20100278885-A1 | C70-Containing Liposome, Method for Producing the Same, and Use of the Same | National University Corporation NARA Institute of Science and Technology (JP) | 2010-11-04 | — | — | US | disclosed |
| EP-2123288-A1 | C<SB>70</SB>-CONTAINING LIPOSOME, METHOD FOR PRODUCING THE SAME, AND USE OF THE SAME | National University Corporation Nara Institute of Science and Technology (JP) | 2009-11-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100278885-A1 | C70-Containing Liposome, Method for Producing the Same, and Use of the Same | LIPA, NPC1L1, PLA2G10 | CA2 2085/4885CA1 1091/4885DGKA 1117/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.